Sharp Therapeutics Corp.
SHRX.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.22M | -1.22M | -2.39M | -1.09M | -187.00K |
| Total Depreciation and Amortization | 22.10K | 22.10K | 23.20K | 25.20K | 23.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -6.30K | -6.30K | 835.10K | 74.30K | -1.31M |
| Change in Net Operating Assets | 66.80K | 66.80K | 559.20K | -132.60K | 149.40K |
| Cash from Operations | -1.14M | -1.14M | -975.60K | -1.12M | -1.33M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 775.00K | 775.00K | -- | -- | -- |
| Total Debt Repaid | -56.10K | -56.10K | -50.00K | -50.00K | -50.00K |
| Issuance of Common Stock | -- | -- | 34.40K | 6.60K | 2.48M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 718.90K | 718.90K | -15.60K | -43.40K | 2.43M |
| Foreign Exchange rate Adjustments | -3.30K | -3.30K | -44.80K | 5.10K | 28.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -426.00K | -426.00K | -1.04M | -1.16M | 1.13M |